The Cooper Companies, Inc. (COO)

Healthcare
Medical Instruments & Supplies
United States
Yahoo Finance  •  Trading View  •  Company site
Price
$68.76
▼ -2.45 (-3.44%)
Market Cap
$13,670,102,016
Shares: 198,900,000
P/E
53.07
P/B: 2.58
ROE
4.85%
Current Ratio: 1.91
Fundamentals Score
47 (NEUTRAL)

Company Overview

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia; and spherical lense, including lenses that correct near and farsightedness in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage to health care professionals and patients worldwide. It offers surgical and office products, including paragard contraceptive intrauterine devices; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.

Headquarters: 6101 Bollinger Canyon Road, San Ramon, CA, 94583, United States  |  Employees: 16000  |  Website: coopercos.com
Key Contacts
IR / Phone: 925 460 3600
Exchange: NMS
Industry: Medical Instruments & Supplies
Quick Financial Snapshot
Revenue$3,895,400,000
Net Income$392,300,000
Free Cash Flow$288,100,000
Book Value / Share$40.64

Balance Sheet & Liquidity

Total Liabilities$4,231,600,000
Total Equity$8,083,400,000
Debt / Equity0.32
Current Ratio1.91
Interest Coverage6.17
Working Capital$928,700,000

Valuation Metrics

Core multiples and valuation signals — useful to compare vs peers.

P/E (TTM)53.07
Industry P/EN/A
Forward P/E16.85
P/B2.58
Price / Sales5.34
P / FCF72.27
EV / EBITDA21.74
Graham Number$42.47
DCF (placeholder)
Notes: red items typically indicate expensive multiples relative to fundamentals. Use the "Compare with industry" tool for context.

EPS (Annual)

Financial Performance

Revenue vs Net Income

Free Cash Flow (annual)

Profitability & Efficiency

Gross Margin 66.64%
Operating Margin 18.12%
Net Margin 10.07%
ROIC 4.20%
Asset Turnover 0.32

Automated Fundamental Signals (Score: 47)

Passed
  • Price CAGR 7.44%
  • Gross Margin 66.6%
  • P/B Ratio 2.58
  • Debt/Equity ratio
  • Operating Margin 18.1%
  • Positive Free Cash Flow
  • Current Ratio
  • Interest Coverage
  • Debt/EBITDA
  • Return on Tangible Assets
Failed
  • EPS shows upward trend
  • EPS CAGR -20.21%
  • ROIC 4.2%
  • P/FCF 72.27
  • CapEx intensity
  • Low reliance on intangibles
  • Price below Graham Number
  • DCF valuation (Overvalued)

Price Chart (Candlestick)

Technical Analysis (Score: 60)

RSI (14)49.18
SMA 5069.45
SMA 20078.48
MACD0.25
Signal NEUTRAL
RSI 49.2, SMA trend bearish, momentum -36.1%.

Governance & Management

Governance scores: Audit: 10 | Board: 8 | Compensation: 8 | Shareholder Rights: 3
Executive Team
NameTitle
Mr. Albert G. White III President, CEO & Non-Independent Director (1970)
Mr. Brian G. Andrews Executive VP, CFO & Treasurer (1979)
Mr. Daniel G. McBride Esq. Executive VP & COO (1964)
Ms. Holly R. Sheffield President of CooperSurgical, Inc. (1971)
Mr. Gerard H. Warner III President of CooperVision, Inc. (1965)
Mr. Agostino Ricupati CPA Senior VP & Chief Accounting Officer (1968)
Mr. Kim Duncan Vice President of Investor Relations & Risk Management (—)
Mr. Nicholas S. Khadder J.D. VP, General Counsel & Corporate Secretary (1974)
Governance data last updated: 10/1/2025

Latest News

No news available for this company.

← Back